ISOPRINOSINE

This brand name is authorized in Ecuador, Lithuania, Mexico, Poland, Romania, Singapore

Active ingredients

The drug ISOPRINOSINE contains one active pharmaceutical ingredient (API):

1 Methisoprinol UNII W1SO0V223F - INOSINE PRANOBEX

Inosine pranobex is a synthetic purine derivative with immunomodulatory and antiviral properties, which result from an apparent in vivo enhancement of host immune responses due to the drug. Read about Inosine pranobex

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J05AX05	Inosine pranobex	J Antiinfectives for systemic use → J05 Antivirals for systemic use → J05A Direct acting antivirals → J05AX Other antivirals
Discover more medicines within J05AX05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 15.387-3-01-06, 15.593-3-10-05, 6048-MEE-0321
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1014829, 1071468
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 76105, 79278
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100032333, 100242190
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W55415001, W55415002, W57941001, W66564001
Country: SG	Health Sciences Authority	Identifier(s): 01361P, 01847P